Drug Extends Overall Survival for Breast Cancer and Liposarcoma

July 01, 2017

FDA Commissioner Aims to Address Drug Pricing Issues; House Republicans Propose 12-Bill Appropriations Omnibus; Adults Don’t Recognize Harm of Vaping Around Kids

Since the campaign trail prior to the presidential election, Donald Trump has been drawing focus to the issue of high drug prices in the United States. In an effort combat the pricing issues, Trump appointed U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, who recently announced the creation of the “drug competition action plan.” The plan would reduce the high cost of drugs in U.S. healthcare market by increasing the efficiency of approving generic medications of name-brand drugs.

June 05, 2017

Pain management

Free AACN Webinar Series Sheds Light on New Opioid Prescription Guidelines

The American Association of Colleges of Nursing (AACN) has announced an upcoming free webinar, “Understanding the CDC Guidelines for Prescribing Opioids for Chronic Pain and Other National Strategies,” for September 22, 2016. This free educational session will outline the changes to the Centers for Disease Control and Prevention’s (CDC’s) opioid prescription guidelines. This webinar comes at a time when healthcare professionals are looking to address the burgeoning opioid epidemic in the United States.

September 20, 2016

Prescription medication

Older Adults May Be Taking Dangerous Medication Combinations

More older adults are taking over-the-counter drugs and supplements with their prescription medications than ever, and as many as 15% of them may be in potentially life-threatening combinations, according to a new study reported in JAMA Internal Medicine.

May 17, 2016

FDA regulations on pain medication labels

Healthcare safety standards

FDA Warns About Opioid Pain Medication and Requires Label Changes

In response to a growing concern about opioid use, the U.S. Food and Drug Administration (FDA) released a warning in March about prescription pain medications. The agency issued new guidelines for labeling to highlight risks associated with the use of certain drugs, including opioids.

April 18, 2016